Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation

Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation

To provide long-term outcome data and predictors for response and survival, we retrospectively analyzed all 151 patients with relapse of myeloid neoplasms after allogeneic hematopoietic stem cell transplantation (allo-HSCT) who were uniformly treated with first-line azacitidine (Aza) salvage therapy...

Full description

Bibliographic Details
Main Authors: Christina Rautenberg, Anika Bergmann, Ulrich Germing, Caroline Fischermanns, Sabrina Pechtel, Jennifer Kaivers, Paul Jäger, Esther Schuler, Rainer Haas, Guido Kobbe, Thomas Schroeder
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cancers
Subjects:
AML
MDS
allogeneic stem cell transplantation
relapse
azacitidine
Online Access:https://www.mdpi.com/2072-6694/12/8/2255

Internet

https://www.mdpi.com/2072-6694/12/8/2255

Similar Items